Difference between revisions of "WSI21-125"

From MGH Learn Pathology
(Edited automatically from page WSI21-125.)
(Edited automatically from page learn:wsidashboard.)
 
(55 intermediate revisions by 9 users not shown)
Line 1: Line 1:
−
{{dziOrderStudySet
+
{{ServiceRequest
−
|order_date=June 30, 2021 08:39:57 PM
+
|intent=order
−
|user=Em99
+
|category=409073007
−
|class_name=Study Set
+
|priority=routine
−
|status=Submitted
+
|code=study
−
|collection_name=Cytopathology
+
|orderDetail=order
−
|class_type=Cytology
+
|authoredOn=June 30, 2021 08:39:57 PM
−
|collection_topic=Kidney and Adrenal Gland
+
|requester=Em99
−
|requested_by=IAC
+
|locationCode=learn
−
|restrict_access=Public
+
|access=public
 +
|subject=MGH
 +
|performer=MGH
 +
|supportingInfo=Cytology
 +
|requisition=Cytology
 +
|reasonCode=Kidney and Adrenal Gland
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Si787
 +
|authoredOn=March 10, 2022 10:38:04 AM
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Jul 21, 2022 14:13:44
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Jul 21, 2022 14:15:14
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Jul 22, 2022 17:19:21
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Tag62
 +
|authoredOn=Jul 28, 2022 16:11:35
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Tag62
 +
|authoredOn=Jul 28, 2022 16:13:49
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Iac0
 +
|authoredOn=Aug 03, 2022 20:42:42
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Iac0
 +
|authoredOn=Aug 03, 2022 20:43:41
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Aug 04, 2022 13:30:27
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Aug 05, 2022 19:25:42
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Aug 10, 2022 14:26:58
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Ndk6
 +
|authoredOn=Nov 01, 2022 12:02:39
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Nov 15, 2022 14:19:42
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Nov 15, 2022 15:16:27
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Nov 30, 2022 20:25:02
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Nov 30, 2022 21:05:10
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Feb 16, 2023 15:15:49
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Feb 16, 2023 15:17:59
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Feb 16, 2023 15:18:40
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Feb 17, 2023 20:50:45
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 03, 2023 14:28:32
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 03, 2023 14:29:57
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 03, 2023 14:30:16
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Ndk6
 +
|authoredOn=Mar 16, 2023 21:25:41
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 22, 2023 15:11:43
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 22, 2023 19:53:41
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 28, 2023 12:59:54
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Mar 28, 2023 13:06:07
 +
}}
 +
{{status
 +
|status=active
 +
|identifier=WSI21-125
 +
|requester=Ndk6
 +
|authoredOn=Apr 13, 2023 16:36:23
 +
}}
 +
{{status
 +
|status=submitted
 +
|identifier=WSI21-125
 +
|requester=Cfh13
 +
|authoredOn=Jun 15, 2023 14:20:12
 +
}}
 +
{{status
 +
|status=received
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Jun 26, 2023 18:36:54
 +
}}
 +
{{status
 +
|status=scanning
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Jun 26, 2023 18:41:49
 +
}}
 +
{{status
 +
|status=completed
 +
|identifier=WSI21-125
 +
|requester=Aja51
 +
|authoredOn=Jul 07, 2023 14:57:16
 
}}
 
}}

Latest revision as of 09:58, July 7, 2023


Request type Study
Subspecialty Cytology
Set Cytology
Topic Kidney and Adrenal Gland
Presenter MGH


Toggle columns: Diagnosis

Case Clinical history Requester Diagnosis
Case Clinical history Requester Diagnosis

Case 1


70yo male with left renal mass Mlz8 Chromophobe renal cell carcinoma

Case 2


63M. Kidney mass. Iac0 Papillary renal cell carcinoma • type I.

Case 3


18 year-old female with a 10 cm renal mass Cfh13 Positive for carcinoma. High grade renal cell carcinoma with a TFE3 fusion.

Case 4


63F. Adrenal mass. Iac0 Burkitt lymphoma.

Case 5


70 year-old male with history of metastatic melanoma • papillary thyroid cancer • PET positive right adrenal nodule. Ndk6 Malignant neoplasm consistent with a metastasis from the patient’s known melanoma

Case 6


78 YO male with h/o lung carcinoma with adrenal mass. Ndk6 Small Cell Carcinoma

Case 7


65 YO female with h/o breast carcinoma and new adrenal mass Ndk6 Adenocarcinoma consistent with breast primary

Case 8


55 YO female with adrenal mass Ndk6 Pheochromocytoma

Case 9


33 yo man with a renal mass. Cfh13 Positive for malignant cells. Consistent with Renal Cell carcinoma.

Case 10


55 yo female with history of metastatic thyroid cancer Ndk6 Metastatic thyroid carcinoma

Case 11


63 yo F w a history of lung cancer Ndk6 Adenocarcinoma consistent with patient's known lung primary

Case 12


72 yo M with a history of NSLC and adrenal mass Ndk6 Adenocarcinoma consistent with patient's known lung primary

Case 13


64 yo M with an enlarged periportal lymph node. Cfh13 Metastatic papillary renal cell carcinoma.

Case 14


36 yo female Dc679 Renal cell carcinoma

Case 15


53F • Renal mass and diffuse adenopathy. Iac0 Renal cell carcinoma with sarcomatoid features

Case 16


67F. Lung mass and left adrenal masses. Iac0 Metastatic non-small cell lung carcinoma

Case 17


42F. Hx of CML. Large renal cyst. Iac0 Cyst contents and small blue cells. Differential diagnosis of metanephric adenoma and cystic partially differentiated nephroblastoma.

Case 18


54 yo male with large right renal mass • query AML and liposarcoma Ndk6 Positive for malignant cells- Highly atypical cells with range of pleomorphism and focal myxoid appearance • suggestive of liposarcoma

Case 19


49 YO male with left renal mass • query lymphoma or RCC. Ndk6 Malignant neoplasm • consistent with seminoma

Case 20


56 y/o male with right kidney mass Kx601 Renal cell carcinoma • clear cell type

Case 21


53 yo female with renal mass and diffuse lymphadenopathy Ndk6 Poorly differentiated carcinoma • consistent with renal cell carcinoma

Case 22


67 yo female with lung mass suspicious for malignancy and also has right larger than left adrenal masses Ndk6 Poorly differentiated non-small cell carcinoma. Note: The aspirate contains numerous high grade • poorly differentiated malignant cells. The tumor cells have macronucleoli • a spindled appearance and are discohesive. The findings are consistent with a poorly differentated non-small cell carcinoma with sarcomatoid features.

Case 23


64 yo M w/ kidney mass Ndk6 Renal cell carcinoma



















Retrieved from "https://learn.mghpathology.org/index.php?title=WSI21-125&oldid=111152"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital